{"entity":{"id":"mount-sinai","kind":"institution","name":"The Mount Sinai Hospital / Tisch Cancer Institute","aka":["Mount Sinai Tisch Cancer Center","Tisch Cancer Institute"],"tldr":"Mount Sinai is a New York academic centre with strengths in myeloma and cancer immunology.","summary":"The Mount Sinai Hospital and its Tisch Cancer Institute form a New York academic centre with NCI clinical designation, ranked thirty-fourth in the Newsweek/Statista oncology list, and its strengths are multiple myeloma and cancer immunology. Its myeloma programme is associated with Sundar Jagannath, its immunology with Miriam Merad and Nina Bhardwaj, and it has a record in neoadjuvant immunotherapy, with Joshua Brody, Thomas U. Marron, Matthew D. Galsky, Josep M. Llovet and Ramon E. Parsons among the people OnCo lists. OnCo links it to the tumour dormancy pathway, to the NIAGARA bladder cancer paper, and to ideas on keeping disseminated cells asleep and on turning one tumour into a vaccine for the others. What decides which disseminated cells ever colonise is the open question its dormancy work asks. Its myeloma and tumour immunology programmes are the ones to read.","asOf":"2026-09-04","links":[{"label":"Official website","url":"https://www.mountsinai.org/care/cancer"}],"tags":[],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["ramon-parsons","miriam-merad","sundar-jagannath","joshua-brody","nina-bhardwaj","thomas-marron","joseph-sparano","josep-llovet","thomas-fuchs","matthew-galsky"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"New York","country":"US","lat":40.79,"lng":-73.953,"institutionType":"hospital","website":"https://www.mountsinai.org/care/cancer","nci":"clinical","newsweekOncology2026":34,"programs":["Myeloma","Tumour immunology"]},"route":"/institutions/mount-sinai/","neighbours":{"cancer":[{"id":"urothelial","kind":"cancer","name":"Bladder & urothelial cancer","route":"/cancers/urothelial/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"person":[{"id":"josep-llovet","kind":"person","name":"Josep M. Llovet","route":"/people/josep-llovet/"},{"id":"joseph-sparano","kind":"person","name":"Joseph A. Sparano","route":"/people/joseph-sparano/"},{"id":"joshua-brody","kind":"person","name":"Joshua Brody","route":"/people/joshua-brody/"},{"id":"matthew-galsky","kind":"person","name":"Matthew D. Galsky","route":"/people/matthew-galsky/"},{"id":"miriam-merad","kind":"person","name":"Miriam Merad","route":"/people/miriam-merad/"},{"id":"nina-bhardwaj","kind":"person","name":"Nina Bhardwaj","route":"/people/nina-bhardwaj/"},{"id":"ramon-parsons","kind":"person","name":"Ramon E. Parsons","route":"/people/ramon-parsons/"},{"id":"sundar-jagannath","kind":"person","name":"Sundar Jagannath","route":"/people/sundar-jagannath/"},{"id":"thomas-fuchs","kind":"person","name":"Thomas J. Fuchs","route":"/people/thomas-fuchs/"},{"id":"thomas-marron","kind":"person","name":"Thomas U. Marron","route":"/people/thomas-marron/"}],"institution":[{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/"},{"id":"new-york-proton-center","kind":"institution","name":"New York Proton Center","route":"/institutions/new-york-proton-center/"},{"id":"parker-institute","kind":"institution","name":"Parker Institute for Cancer Immunotherapy","route":"/institutions/parker-institute/"}],"idea":[{"id":"idea-dormancy-maintenance-therapy","kind":"idea","name":"Keep them asleep: dormancy maintenance as adjuvant therapy","route":"/ideas/idea-dormancy-maintenance-therapy/"},{"id":"idea-bio2-in-situ-vaccination-solid","kind":"idea","name":"Turn one tumour into a vaccine to treat all the others","route":"/ideas/idea-bio2-in-situ-vaccination-solid/"},{"id":"idea-dtc-colonisation-determinants","kind":"idea","name":"What decides which disseminated cells ever colonise?","route":"/ideas/idea-dtc-colonisation-determinants/"}],"pathway":[{"id":"tumor-dormancy","kind":"pathway","name":"Tumour dormancy","route":"/pathways/tumor-dormancy/"}],"paper":[{"id":"paper-niagara-nejm-2024","kind":"paper","name":"NIAGARA: durvalumab before and after cystectomy for muscle-invasive bladder cancer","route":"/key-papers/paper-niagara-nejm-2024/"}]}}